Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Taxes (2021 - 2025)

Collegium Pharmaceutical has reported Current Taxes over the past 5 years, most recently at $797000.0 for Q3 2025.

  • Quarterly results put Current Taxes at $797000.0 for Q3 2025, down 25.23% from a year ago — trailing twelve months through Sep 2025 was $797000.0 (down 25.23% YoY), and the annual figure for FY2024 was $8.5 million, up 299.11%.
  • Current Taxes for Q3 2025 was $797000.0 at Collegium Pharmaceutical, up from $328000.0 in the prior quarter.
  • Over the last five years, Current Taxes for COLL hit a ceiling of $14.1 million in Q1 2024 and a floor of $36000.0 in Q3 2021.
  • Median Current Taxes over the past 5 years was $931500.0 (2024), compared with a mean of $3.3 million.
  • Biggest five-year swings in Current Taxes: soared 299.11% in 2024 and later tumbled 38.35% in 2025.
  • Collegium Pharmaceutical's Current Taxes stood at $622000.0 in 2021, then soared by 228.46% to $2.0 million in 2022, then increased by 4.55% to $2.1 million in 2023, then soared by 299.11% to $8.5 million in 2024, then crashed by 90.65% to $797000.0 in 2025.
  • The last three reported values for Current Taxes were $797000.0 (Q3 2025), $328000.0 (Q2 2025), and $9.0 million (Q1 2025) per Business Quant data.